This text is a result of machine translation.
IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives
In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow
May 09, 2024 12:18 PM
China’s OpenAI Challenger Zhipu AI Secures Over CNY 2.5 Billion to Step Further on Large-Scale Model
4Paradigm Initiates IPO Today and Targets HKSE on September 28
Power Device Company Maplesemi Completes Series A+ Financing Round
Acoustic Technology Company Audfly Completes Series B Financing Round
Wicue Raised CNY 200 Mn in Series C+ Financing Round
Jinyu medicine: we are actively cooperating in the investigation of Jinyu incident in Zhengzhou
Gilid signed an agreement with science and technology to deepen strategic cooperation in the areas of chronic hepatitis B, hepatitis C and HIV infection.
Back to Hong Kong, Chinese concept stocks rose collectively, and Wanguo data rose 17.5%
360 Billion: How Can Chinese Companies Grow Together with Africa
Sep 27, 2024 06:30 PM